Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 101.3 | 74.0 | 32.9 | 24.0 |
| Revenue growth | 36.9% | 124.8% | 37.4% | |
| Cost of goods sold | 186.2 | 194.7 | 120.6 | 203.7 |
| Gross profit | -84.9 | -120.7 | -87.7 | -179.8 |
| Gross margin | -83.8% | -163.1% | -266.4% | -750.5% |
| Selling, general and administrative | 159.7 | 131.2 | 74.0 | 73.5 |
| Research and development | 70.3 | 93.5 | 68.8 | 74.9 |
| EBIT | -331.8 | -345.4 | -230.5 | -328.2 |
| EBIT margin | -327.5% | -466.7% | -700.0% | -1369.9% |
| Pre-tax income | -336.9 | -343.4 | -249.7 | -312.1 |
| Income taxes | 0.1 | -0.4 | 0.0 | 0.1 |
| Tax rate | | 0.1% | | |
| Net income | -337.1 | -343.0 | -249.7 | -312.1 |
| Net margin | -332.7% | -463.4% | -758.4% | -1302.9% |
| |
| Diluted EPS | ($1.56) | ($1.97) | ($148.81) | ($198.66) |
| Shares outstanding (diluted) | 215.6 | 173.7 | 1.7 | 1.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|